GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Senomyx Inc (NAS:SNMX) » Definitions » ROC (Joel Greenblatt) %

Senomyx (Senomyx) ROC (Joel Greenblatt) % : -618.76% (As of Jun. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Senomyx ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Senomyx's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2018 was -618.76%.

The historical rank and industry rank for Senomyx's ROC (Joel Greenblatt) % or its related term are showing as below:

SNMX's ROC (Joel Greenblatt) % is not ranked *
in the Chemicals industry.
Industry Median: 10.06
* Ranked among companies with meaningful ROC (Joel Greenblatt) % only.

Senomyx's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Senomyx ROC (Joel Greenblatt) % Historical Data

The historical data trend for Senomyx's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senomyx ROC (Joel Greenblatt) % Chart

Senomyx Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -175.96 -256.89 -354.02 -238.77 -22.33

Senomyx Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -211.44 -174.32 455.80 -348.96 -618.76

Competitive Comparison of Senomyx's ROC (Joel Greenblatt) %

For the Specialty Chemicals subindustry, Senomyx's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senomyx's ROC (Joel Greenblatt) % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Senomyx's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Senomyx's ROC (Joel Greenblatt) % falls into.



Senomyx ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Mar. 2018 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.833 + 1.632 + 0.398) - (3.481 + 0.343 + 0.219)
=-0.18

Working Capital(Q: Jun. 2018 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.186 + 1.891 + 0.317) - (3.816 + 0.35 + 0.219)
=0.009

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Senomyx for the quarter that ended in Jun. 2018 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2018 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2018  Q: Jun. 2018
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-14.844/( ( (2.451 + max(-0.18, 0)) + (2.338 + max(0.009, 0)) )/ 2 )
=-14.844/( ( 2.451 + 2.347 )/ 2 )
=-14.844/2.399
=-618.76 %

Note: The EBIT data used here is four times the quarterly (Jun. 2018) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senomyx  (NAS:SNMX) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Senomyx ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Senomyx's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Senomyx (Senomyx) Business Description

Traded in Other Exchanges
N/A
Address
Senomyx Inc manufactures and sells a variety of favors for the packaged food, beverage, and ingredient supply industries. The firm's product portfolio has three primary categories: sweetmyx, savorymyx, and bittermyx. Sweetmyx ingredients are used to increase a product's sweet taste while reducing sugar usage. Savorymyx ingredients are used to increase a product's savory flavors as well as reduce MSG, nucleotides, and sodium in food and beverage products. Bittermyx ingredients are used to reduce a product's bitter taste.
Executives
Christopher J Twomey director 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA 92121
John Poyhonen director, officer: President & CEO 11088 N TORREY PINES RD, C/O SENOMYX INC, LA JOLLA CA 92037
Stephen A Block director INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 WEST 57TH ST, NEW YORK NY 10019
Mary Ann Gray director 201 W 70TH ST, SUITE 23K, NEW YORK NY 10023
Richard R Mashaal 10 percent owner C/O RIMA SENVEST MANAGEMENT, L.L.C., 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Senvest Management, Llc 10 percent owner 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Michael E Herman director CERNER CORP 2800 ROCKCREEK PARKWAY KANSAS CITY MO 64117-2551
David B Berger officer: Sr. V.P. Gen. Counsel & Sec. 11045 ROSELLE STREET, SAN DIEGO CA 92121
Dennis F Obrien director SENOMYX INC, 11099 NORTH TORREY PINES ROAD, LA JOLLA CA 92037
Harry J Leonhardt officer: SVP, Gen.Counsel & Corp. Sec. C/O HALOZYME THERAPEUTICS, INC., 11388 SORRENTO VALLEY BLVD., SAN DIEGO CA 92121
Mark Leschly director RHO CAPITAL PARTNERS, INC., 152 W 57TH ST 23RD FL, NEW YORK NY 10019
David Schnell director 525 UNIVERSITY AVE, SUITE 1350, PALO ALTO CA 94301
Timothy J Wollaeger director
Beeley Nigel R A officer: VP Discovery ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVER SAN DIEGO CA 92121
Rho Management Trust I 10 percent owner C/O RHO CAPITAL PARTNERS, INC., 152 W. 57TH STREET, 23RD FLOOR, NEW YORK NY 10019

Senomyx (Senomyx) Headlines